Factorial design optimization and in vivo feasibility of poly(ε-caprolactone)-micro- and nanofiber-based small diameter vascular grafts

Journal of Biomedical Materials Research - Part A

Volumn 89, Issue 4, 2009, Pages 865-875

  Nottelet, B ^a   Pektok, E ^b   Mandracchia, D ^a,c   Tille, J C ^b   Walpoth, B ^b   Gurny, R ^a   Möller, Michael ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c UNIVERSITY OF BARI   (Italy)

Author keywords

Biodegradable polymers; Electrospinning; In vivo study; Nanofibers; Polycaprolactone; Vascular grafts

Indexed keywords

APPLIED VOLTAGES; BLOOD VESSEL SUBSTITUTES; CAPROLACTONE; CARDIO-VASCULAR DISEASE; CELL INGROWTH; FACTORIAL DESIGN APPROACH; FACTORIAL DESIGN OPTIMIZATION; FEASIBILITY STUDIES; IMPLANTATION PERIODS; IN VIVO STUDY; IN-VIVO; INNER DIAMETERS; POLYMER CONCENTRATIONS; SMALL DIAMETER VASCULAR GRAFTS; VASCULAR GRAFTS;

BIODEGRADABLE POLYMERS; BLOOD VESSELS; ELECTROSPINNING; GRAFTING (CHEMICAL); NANOFIBERS; OPTIMIZATION; PLANNING; RESOURCE ALLOCATION; SULFUR COMPOUNDS; TENSILE STRAIN; TISSUE ENGINEERING;

GRAFTS;

NANOFIBER; POLYCAPROLACTONE;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL CIRCULATION; ARTICLE; BIOENGINEERING; BLOOD VESSEL GRAFT; CONTROLLED STUDY; FACTORIAL DESIGN; FEASIBILITY STUDY; FLOW RATE; IMPLANTATION; IN VIVO STUDY; NONHUMAN; RAT; STRESS FIBER;

ANGIOGRAPHY; ANIMALS; BLOOD VESSEL PROSTHESIS; BLOOD VESSELS; FEASIBILITY STUDIES; IMPLANTS, EXPERIMENTAL; NANOSTRUCTURES; PILOT PROJECTS; POLYESTERS; RATS; SOLVENTS; SURFACE PROPERTIES; TENSILE STRENGTH; TISSUE ENGINEERING;

EID: 66249116318     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32023     Document Type: Article

References (63)

1. Avendano M, Kunst AE, Huisman M, Lenthe FV, Bopp M, Regidor E, Glickman M, Costa G, Spadea T, Deboosere P, Borrell C, Valkonen T, Gisser R, Borgan JK, Gadeyne S, Mackenbach JP. Socioeconomic status and ischaemic heart disease mortality in 10 western European populations during the 1990s. Heart 2006;92:461-467.
2. Ounpuu S, Anand S, Yusuf S. The impending global epidemic of cardiovascular diseases. Eur Heart J 2000;21:880-883.
3. Rodengen JL, Stephensen LW. Coronary artery disease and treatment options. In: Rodengen JL, Stephensen LW, editors. The Practical Guide to Your Heart and Heart Surgery. Fort Lauderdale, FL: Write Stuff Enterprises Inc.; 1999. pp 110-129.
4. Tomizawa Y. Vascular prostheses for aortocoronary bypass- grafting-A review. Artif Organs 1995;19:39-45.
5. Emery RW, Mills NL, Teijeira FJ, Arom KV, Baldwin P, Petersen RJ, Joyce LD, Grinnan GLB, Sussman MS, Copeland JG, Ochsner JL, Boyce SW, Nicoloff DM. North American experience with the perma-flow prosthetic coronary graft. Ann Thorac Surg 1996;62:691-695.
6. Brockbank KGM, Mcnally RT, Walsh KA. Cryopreserved vein transplantation. J Cardiac Surg 1992;7:170-176.
7. Teebken OE, Haverich A. Tissue engineering of small diameter vascular grafts. Eur J Vase Endovasc 2002;23:475-485.
8. Walpoth BH, Rogulenko R, Tikhvinskaia E, Gogolewski S, Schaffner T, Hess OM, Althaus U. Improvement of patency rate in heparin-coated small synthetic vascular grafts. Circulation 1998;98:11319-11323.
9. 121 induced enhancement of cellular coverage of ePTFE grafts in the chronic pig model. Joint Meeting of the Tissue Engineering Society International and the European Tissue Engineering Society. 2004.
10. Crombez M, Chevallier P, Gaudreault RC, Petitclerc E, Man- tovani D, Laroche G. Improving arterial prosthesis neo-endothelialization: Application of a proactive VEGF construct onto PTFE surfaces. Biomaterials 2005;26:7402-7409.
11. Suma H, Wanibuchi Y, Terada Y, Fukuda S, Takayama T, Furuta S. The right gastroepiploic artery graft-Clinical and angiographic midterm results in 200 patients. J Thorac Car- diov Sur 1993;105:615-623.
12. Stock UA, Wiederschain D, Kilroy SM, Shum-Tim D, Khalil PN, Vacanti JP, Mayer JE, Moses MA. Dynamics of extracellular matrix production and turnover in tissue engineered cardiovascular structures. J Cell Biochem 2001;81:220-228.
13. Kadner A, Zund G, Maurus C, Breymann C, Yakarisik S, Kadner G, Turina M, Hoerstrup SP. Human umbilical cord cells for cardiovascular tissue engineering: A comparative study. Eur J Cardiothorac Surg 2004;25:635-641.
14. McFetridge PS, Bodamyali T, Horrocks M, Chaudhuri JB. Endothelial and smooth muscle cell seeding onto processed ex vivo arterial scaffolds using 3D vascular bioreactors. ASAIO J 2004;50:591-600.
15. Nasseri BA, Pomerantseva I, Kaazempur-Mofrad MR, Sutherland FWH, Perry T, Ochoa E, Thompson CA, Mayer JE, Oesterle SN, Vacanti JP. Dynamic rotational seeding and cell culture system for vascular tube formation. Tissue Eng 2003; 9:291-299.
16. Williams C, Wick TM. Perfusion bioreactor for small diameter tissue-engineered arteries. Tissue Eng 2004;10:930-941.
17. Lanza RP, Langer R, Vacanti JP. Principles of Tissue Engineering. San Diego: Academic Press; 2000.
18. Stevens MM, George JH. Exploring and engineering the cell surface interface. Science 2005;310:1135-1138.
19. Ashammakhi N, Ndreu A, Yang Y, Ylikauppila H, Nikkola L, Hasirci V. Tissue engineering: A new take-off using nano- fiber-based scaffolds. J Cranofac Sur 2007;18:3-17.
20. Li D, Xia YN. Electrospinning of nanofibers: Reinventing the wheel? Adv Mater 2004;16:1151-1170.
21. Huang ZM, Zhang YZ, Kotaki M, Ramakrishna S. A review on polymer nanofibers by electrospinning and their applications in nanocomposites. Compos Sci Technol 2003;63:2223- 2253.
22. Chew SY, Wen Y, Dzenis Y, Leong KW. The role of electrospinning in the emerging field of nanomedicine. Curr Pharm Design 2006;12:4751-4770.
23. Xu CY, Inai R, Kotaki M, Ramakrishna S. Electrospun nano- fiber fabrication as synthetic extracellular matrix and its potential for vascular tissue engineering. Tissue Eng 2004;10: 1160-1168.
24. Boland ED, Matthews JA, Pawlowski KJ, Simpson DG, Wnek GE, Bowlin GL. Electrospinning collagen and elastin: Preliminary vascular tissue engineering. Front Biosci 2004;9:1422- 1432.
25. Buttafoco L, Kolkman NG, Engbers-Buijtenhuijs P, Poot AA, Dijkstra PJ, Vermes I, Feijen J. Electrospinning of collagen and elastin for tissue engineering applications. Biomaterials 2006;27:724-734.
26. Remuzzi A, Mantero S, Colombo M, Morigi M, Binda E, Camozzi D, Imberti B. Vascular smooth muscle cells on hyaluronic acid: Culture and mechanical characterization of an engineered vascular construct. Tissue Eng 2004;10:699-710.
27. Arrigoni C, Camozzi D, Imberti B, Mantero S, Remuzzi A. The effect of sodium ascorbate on the mechanical properties of hyaluronan-based vascular constructs. Biomaterials 2006; 27:623-630.
28. Lee JH, Kim WG, Kim SS, Lee JH, Lee HB. Development and characterization of an alginate-impregnated polyester vascular graft. J Biomed Mater Res 1997;36:200-208.
29. Lu J-W, Zhu Y-L, Guo Z-X, Hu P, Yu J. Electrospinning of sodium alginate with poly(ethylene oxide). Polymer 2006;47: 8026-8031.
30. Wnek GE, Carr ME, Simpson DG, Bowlin GL. Electrospinning of nanofiber fibrinogen structures. Nano Lett 2003;3:213- 216.
31. Morton T, Nikkola L, Ashammakhi N, Wolbank S, Peterbauer A, van Griensven M, Redl H. Electrospun fibrinogen and fibrin nanofibers for angiogenesis in vitro. Wound Repair Regen 2007;I5:A48.
32. Miller DC, Thapa A, Haberstroh KM, Webster TJ. Endothelial and vascular smooth muscle cell function on poly(lactic-co- glycolic acid) with nano-structured surface features. Biomaterials 2004;25:53-61.
33. Iwai S, Sawa Y, Ichikawa H, Taketani S, Uchimura E, Chen GP, Hara M, Miyake J, Matsuda H. Biodegradable polymer with collagen microsponge serves as a new bioengineered cardiovascular prosthesis. J Thorac Cardiov Sur 2004;128:472-479.
34. Boland ED, Pawlowski KJ, Barnes CP, Simpson DG, Wnek GE, Bowlin GL. Electrospinning of bioresorbable polymers for tissue engineering scaffolds. ACS Sym Ser. 2006;918 (Polymeric Fibers): 188-204.
35. Li WJ, Cooper JA, Mauck RL, Tuan RS. Fabrication and characterization of six electrospun poly(a-hydroxy ester)-based fibrous scaffolds for tissue engineering applications. Acta Biomater 2006;2:377-385.
36. Patel HJ, Su SH, Patterson C, Nguyen KT. A combined strategy to reduce restenosis for vascular tissue engineering applications. Biotechnol Progr 2006;22:38-44.
37. Bacakova L, Lapcikova M, Kubies D, Rypacek F. Adhesion and growth of rat aortic smooth muscle cells on lactide-based polymers. Adv Exp Med Biol 2003;534:179-189.
38. Buttafoco L, Boks NP, Engbers-Buijtenhuijs P, Grijpma DW, Poot AA, Dijkstra PJ, Vermes I, Feijen J. Porous hybrid structures based on P(DLLA-co-TMC) and collagen for tissue engineering of small-diameter blood vessels. J Biomed Mater Res B 2006;79B:425-434.
39. Zhang J, Qi HX, Wang HJ, Hu P, Ou LL, Guo SH, Li J, Che YZ, Yu YT, Kong DL. Engineering of vascular grafts with genetically modified bone marrow mesenchymal stem cells on poly (propylene carbonate) graft. Artif Organs 2006;30: 898-905.
40. Cikirikciouglu M, Bowlin G, Cikirikciouglu YB, E>jebaili K, Tatar T, Kalangos A, Walpoth BH. Biodegradable poly-dioxa- none grafts for replacement of the abdominal aorta in the rat model. Br J Surg 2005;92:915.
41. Zeng J, Chen XS, Liang QZ, Xu XL, Jing XB. Enzymatic degradation of poly(L-lactide) and poly (epsilon-caprolactone) electrospun fibers. Macromol Biosci 2004;4:1118-1125.
42. Huang ZM, He CL, Yang A, Zhang Y, Han XJ, Yin J, Wu Q. Encapsulating drugs in biodegradable ultrafine fibers through co-axial electrospinning. J Biomed Mater Res A 2006;77A:169- 179.
43. Bolgen N, Menceloglu YZ, Acatay K, Vargel I, Piskin E. In vitro and in vivo degradation of non-woven materials made of poly(e-caprolactone) nanofibers prepared by electrospinning under different conditions. J Biomater Sci Polym Ed 2005;16:1537-1555.
44. Linnemann B, Ali R, Gries T, Grafahrend D, Klee D, Moeller M, Roth G. Electrospinning: Nanofiber from polycaprolactone (PCL). Chem Fibers Int 2005;55:370-372.
45. Jeun JP, Lim YM, Nho YC. Study on morphology of electrospun poly(caprolactone) nanofiber. J Ind Eng Chem 2005;11: 573-578.
46. Hsu CM, Shivkumar S. Nano-sized beads and porous fiber constructs of poly(E-caprolactone) produced by electrospinning. J Mater Sci 2004;39:3003-3013.
47. Li WJ, Danielson KG, Alexander PG, Tuan RS. Biological response of chondrocytes cultured in three-dimensional nanofibrous poly(epsilon- caprolactone) scaffolds. J Biomed Mater Res A 2003;67A.T105-1114.
48. Li WJ, Tuli R, Huang XX, Laquerriere P, Tuan RS. Multiline- age differentiation of human mesenchymal stem cells in a three-dimensional nanofibrous scaffold. Biomaterials 2005;26: 5158-5166.
49. Venugopal J, Ma LL, Yong T, Ramakrishna S. In vitro study of smooth muscle cells on polycaprolactone and collagen nanofibrous matrices. Cell Biol Int 2005;29:861-867.
50. Venugopal JR, Zhang YZ, Ramakrishna S. In vitro culture of human dermal fibroblasts on electrospun polycaprolactone collagen nanofibrous membrane. Artif Organs 2006;30:440-446.
51. Serrano MC, Pagani R, Vallet-Regi M, Pena J, Ramila A, Izquierdo I, Portoles MT. In vitro biocompatibility assessment of poly(epsilon-caprolactone) films using L929 mouse fibroblasts. Biomaterials 2004;25:5603-5611.
52. Vaz CM, Van Tuijl S, Bouten CVC, Baaijens FPT. Design of scaffolds for blood vessel tissue engineering using a multi- layering electrospinning technique. Acta Biomater 2005;1:575- 582.
53. Pham QP, Sharma U, Mikos AG. Electrospun poly(epsiloncaprolactone) microfiber and multilayer nanofiber/microfiber scaffolds: Characterization of scaffolds and measurement of cellular infiltration. Biomacromolecules 2006;7:2796-2805.
54. Zong XH, Ran SF, Fang DF, Hsiao BS, Chu B. Control of structure, morphology and property in electrospun poly (glyclodide-co-lactide) non-woven membranes via post-draw treatments. Polymer 2003;44:4959-4967.
55. Im JN, Kim JK, Kim HK, In CH, Lee KY, Park WH. In vitro and in vivo degradation of synthetic absorbable bicomponent monofilament suture prepared with poly(p-dioxanone) and its copolymer. Polym Degrad Stabil 2007;92:667-674.
56. Williamson MR, Black R, Kielty C. PCL-PU composite vascular scaffold production for vascular tissue engineering: Attachment, proliferation and bioactivity of human vascular endothelial cells. Biomaterials 2006;27:3608-3616.
57. Yarin AL, Kataphinan W, Reneker DH. Branching in electro- spinning of nanofibers. J Appl Phys 2005,98:064501/1-064501/12.
58. McManus MC, Boland ED, Koo HP, Barnes CP, Pawlowski KJ, Wnek GE, Simpson DG, Bowlin GL. Mechanical properties of electrospun fibrinogen structures. Acta Biomater 2006;2:19-28.
59. Valenta J. Clinical Aspects of Biomedecine. Amsterdam: Elsevier Science; 1993.
60. Evans FG. Strength of Biological Materials. Baltimore: Williams & Wilkins; 1980.
61. Fong H, Chun I, Reneker DH. Beaded nanofibers formed during electrospinning. Polymer 1999;40:4585-4592.
62. Deitzel JM, Kleinmeyer J, Harris D, Tan NCB. The effect of processing variables on the morphology of electrospun nanofibers and textiles. Polymer 2001;42:261-272.
63. Zhang Z, Wang Z, Liu S, Kodama M. Pore size, tissue ingrowth, and endothelialization of small-diameter micro- porous polyurethane vascular prostheses. Biomaterials 2004; 25:177-187.